Types of vaccines against PRRS

At present, there are over 30 vaccines, although some of them are only available in their country of origin. Virtually, all these vaccines are based on live virus (modified live virus, MLV) or inactivated virus (IV), both on PRRSV1 and PRRSV2 -there are only two exceptions based on PRRSV2 subunits-, being MLVs the predominating vaccines used in the field nowadays.


So… are the current PRRS virus vaccines useful?

Although several vaccines are available worldwide, we know that they do not provide full and universal protection against PRRS virus infection. As stated above, there are two main reasons behind this problem: • The virus has high genetic diversity. • The virus strongly modulates the immune responses.


Can we predict protection between strains?

Unfortunately, at present the answer is absolutely negative. It is not possible to predict the level of protection that a given field strain or vaccine will afford against an infection with a new strain. As it has been discussed, the virus variability is extreme in many aspects (see section What is the PRRS virus?).


Immunisation of gilts and sows

Immunisation of gilts: Two of the most frequent methods to immunise gilts are Inoculation/contact of live-resident virus. Immunisation with live-resident virus is usually performed by using contact to presumably infected material, such as feces or animals, or by sera inoculation from a viremic piglet. Both strategies are potentially dangerous and the outcome is unpredictable.


Immunisation of piglets

The use of commercial vaccines should be the only possible option to immunise piglets. To vaccinate piglets, two important points must be considered in order to choose the best moment: • The development of immunity will require at least 3 weeks. • Maternal antibodies can interfere with the vaccines.


Routes of administration: Intramuscular versus intradermal

Currently all commercial vaccines are indicated for intramuscular administration. However, few of them are also indicated to inject by intradermal route. Compared to conventional intramuscular administration, intradermal injection in pigs are usually carried out using needle-free jet injectors. Needle-free administration in dermis offers important practical and immunity advantages over conventional intramuscular administration by methods based on needles and syringes:


What is the role of NAs and cell-mediated immunity?

Viral clearance after infection: Passive transfer studies have demonstrated that specific antibodies against PRRS virus are capable of protecting animals from homologous challenge. However, the role of NAs in the course of infection is a controversial issue. While some authors have reported a certain correlation between the appearance of NAs and the cease of viraemia or the clearance of the virus from lungs, other studies have suggested that for some strains, clearance of viraemia can occur without NAs; even more, viraemia and viral replication can persist even in the presence of NAs. In relation to cell-mediated immunity, some studies have reported that IFN-γ may be associated with viral clearance in the absence of NAs.



      I have read and agree to the Privacy Policy and Basic information on Data Protection.

      Informazioni di base sulla protezione dei dati personali:

      Titolare del trattamento: LABORATORIOS HIPRA, S.A.
      Finalità: Gestione del rapporto contrattuale e/o commerciale con HIPRA, incluso l’invio di notizie, promozioni e inviti a eventi sponsorizzati da HIPRA.
      Base giuridica: Esecuzione del rapporto contrattuale e del legittimo interesse di HIPRA.
      Destinatari: Terzi a cui HIPRA ha affidato servizi di cloud computing, sicurezza, auditing, mailing, supporto tecnico e informatico, nonché società del suo gruppo.
      Diritti: Richiedere l'accesso e la rettifica o la cancellazione dei dati personali e altri diritti come spiegato nelle informazioni aggiuntive. Puoi vedere le informazioni aggiuntive dettagliate sulla protezione dei dati nella nostra Informativa sulla privacy.

      Per ulteriori informazioni, puoi consultare le nostre informazioni dettagliate sulla Protezione dei dati.


      目的: 管理與海博萊的合約和/或業務關係,包括發送新聞、宣傳和海博萊贊助的活動邀請。
      法律依據: 合約關係的履行和海博萊的合法利益。
      接收者: 海博萊委託提供雲端運算、安全、稽核、郵寄、技術和電腦支援服務的第三方以及其集團內的公司。
      權利: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

      For further information, please check our detailed information on Data Protection.

      Basic Personal Data Protection information:

      Controller: LABORATORIOS HIPRA, S.A.
      Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
      Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
      Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
      Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

      For further information, please check our detailed information on Data Protection.

      Información básica sobre protección de datos:

      Responsable del tratamiento: LABORATORIOS HIPRA, S.A.
      Propósitos: Gestionar la relación contractual y comercial con HIPRA, incluido el envío de noticias, promociones e invitaciones a eventos patrocinados por HIPRA.
      Fundamentos legales: Cumplimiento de la relación contractual e interés legítimo de HIPRA.
      Destinatarios: Terceros a los que HIPRA ha encargado las tareas de computación en la nube, seguridad, auditoría, correo, servicios de soporte técnico e informático, así como empresas de su grupo.
      Derechos: Solicitar el acceso y la rectificación o eliminación de los datos personales y otros derechos, tal como se explica en la información adicional. Puede ver la información adicional detallada sobre la protección de datos en nuestra Política de Privacidad.

      Para obtener más información, consulte nuestra información detallada sobre Protección de datos.